GL1X · GenesisL1 explorer

Research workbench

Structure of the C. glutamicum acnr crystal form II

Analyse Structure of the C. glutamicum acnr crystal form II in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4ACI
Type
protein
Length
353 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hth-type transcriptional repressor acnr
UniProt
Q8NQ97
Ligands
MG, NA
Pockets
7 · best druggability 0.71

Structure

x-ray diffraction · 2 distinct chains · 80% helix, 1% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHth-type transcriptional repressor acnrprotein17683% helix, 1% strandQ8NQ97
BHth-type transcriptional repressor acnrprotein17777% helix, 1% strandQ8NQ97

Ligands and binding sites

  • MG · Magnesium ion · metal · 2 copies · chains A, B
  • NA · Sodium ion · metal · chains B
  • GOL · Glycerol · additive · 2 copies · chains A
  • CIT · Citric acid · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13880.710.8230empty
22830.680.8330empty
3870.610.8816MG, CIT
4830.590.8817MG, CIT
51300.550.8221empty

Interfaces

1 interface between chains.

  • A–B · 1634 Ų buried · 21 hydrogen bonds · protein-protein

Compared structures

  • 4ACI · Structure of the C. glutamicum AcnR Crystal Form II · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8NQ97 · AlphaFold monomer V2.0 prediction for hth-type transcriptional repressor acnr (Q8NQ97) · a predicted model of the same protein · chain B against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.